Preliminary data from Israel this week regarding Pfizer’s vaccine for the coronavirus is raising questions about how vaccines work over time against variants like delta. To break this down, host Marco Werman speaks with Dr. Anna Durbin, a professor of international health at Johns Hopkins Bloomberg School of Public Health. Durban explains why she still doesn’t find such results worrying.
The article you just read is free because dedicated readers and listeners like you chose to support our nonprofit newsroom. Our team works tirelessly to ensure you hear the latest in international, human-centered reporting every weekday. But our work would not be possible without you. We need your help.
Make a gift today to help us reach our $25,000 goal and keep The World going strong. Every gift will get us one step closer.